TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
31.51
+2.74 (9.52%)
At close: Mar 17, 2026, 4:00 PM EDT
31.43
-0.08 (-0.25%)
After-hours: Mar 17, 2026, 6:49 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Product Revenue, Net
606.93M313.73M
Product Revenue, Net Growth
93.46%240.99%
License Revenue
152.00K152.00K
License Revenue Growth
--99.89%
Milestone Revenue
-12.50M
Royalty Revenue
5.62M801.00K
Royalty Revenue Growth
601.00%-
Other Revenue
3.59M1.82M
Other Revenue Growth
97.04%21.21%
Total License, Milestone, Royalty and Other Revenue
9.36M15.28M
Total License, Milestone, Royalty and Other Revenue Growth
-38.73%-89.22%
Revenue (Other)
-9.21M-15.12M
Revenue (Total)
616.29M329.00M
Revenue (Total) Growth
87.32%40.80%
Updated Feb 26, 2026. Data Source: Fiscal.ai.